Leveraging Technological Advances to Overcome the Challenges of HIV Vaccine Development

Over the past three decades, HIV-1 infection has transformed from a progressive fatal disease to a stable and manageable chronic viral infection, thanks to consistent advances in antiretroviral (ARV) drug treatments. Yet, despite this progress, more than 1 million people died from AIDS-related illnesses last year. The greatest hope to control and eventually defeat the ongoing global HIV/AIDS epidemic is through an effective vaccine.

Join Christos Petropoulos, Chief Scientific Officer, Monogram Biosciences and Vice President, LabCorp, as he discusses recent technological advances that have illuminated promising new approaches for immunogen design, vaccine delivery and vaccination. He’ll also discuss the scientific challenges faced and vaccine development opportunities that are re-invigorating the pursuit of an HIV vaccine.